Bridgepoint Development Capital has acquired Quotient Clinical, a provider of early stage drug development services, from the Quotient Bioresearch Group. Quotient Clinical offers a platform that uses an integrated approach to formulation development, realtime drug product manufacturing and clinical testing.   Quotient Clinical employs more than 200 people and has two facilities in the UK. The principal site in Nottingham has an 85-bed clinical pharmacology unit with an integrated drug manufactur...